Literature DB >> 1954912

Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion.

B M Drees1, J Rouse, J Johnson, J W Hamilton.   

Abstract

Chromogranin-A (CgA) is a ubiquitous protein which colocalizes in secretory granules of multiple endocrine tissues and cosecretes with peptide hormones from these tissues. Although the function of CgA has remained unknown, there has been recent interest in its potential role as a prohormone for smaller, biologically active peptides. We isolated and characterized a 26-kDa N-terminal fragment of CgA which is a natural breakdown product of bovine parathyroid CgA in storage. A similar, if not identical, fragment of CgA is secreted by bovine parathyroid glands. The secreted fragment elutes on HPLC and migrates on both sodium dodecyl sulfate-polyacrylamide gel electrophoresis and acid-urea gels in the same position as the 26-kDa N-terminal fragment. When added to the incubation medium of dispersed bovine parathyroid cells, the 26-kDa N-terminal fragment of CgA inhibits the low calcium-stimulated secretion of both PTH and CgA. This N-terminal fragment is homologous to betagranin, which is a 21-kDa N-terminal fragment of CgA that is generated from CgA in rat insulin granules. Thus, a naturally occurring betagranin-like N-terminal fragment of bovine parathyroid CgA is not only secreted itself, but can inhibit the secretion of PTH and intact CgA by bovine parathyroid cells. The processing of intact CgA to fragments such as the N-terminal fragment that we describe may be important in the autocrine or paracrine regulation of secretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954912     DOI: 10.1210/endo-129-6-3381

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  The chromogranins and the counter-regulatory hormones: do they make homeostatic sense?

Authors:  J H Koeslag; P T Saunders; J A Wessels
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

2.  Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.

Authors:  N L Eskeland; A Zhou; T Q Dinh; H Wu; R J Parmer; R E Mains; D T O'Connor
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

Authors:  S K Mahata; D T O'Connor; M Mahata; S H Yoo; L Taupenot; H Wu; B M Gill; R J Parmer
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 4.  The adrenal chromaffin granule: a model for large dense core vesicles of endocrine and nervous tissue.

Authors:  H Winkler
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

5.  Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues.

Authors:  R Kirchmair; B Leitner; R Fischer-Colbrie; J Marksteiner; R Hogue-Angeletti; H Winkler
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

6.  Novel peptides from adrenomedullary chromaffin vesicles.

Authors:  J Sigafoos; W G Chestnut; B M Merrill; L C Taylor; E J Diliberto; O H Viveros
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

7.  Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.

Authors:  I Tsigelny; S K Mahata; L Taupenot; N E Preece; M Mahata; I Khan; R J Parmer; D T O'Connor
Journal:  Regul Pept       Date:  1998-10-16

Review 8.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

9.  Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies.

Authors:  Long Jin; Shuya Zhang; Jill Bayliss; Bernd Scheithauer; Xiang Qian; Ikuo Kobayashi; Mats Stridsberg; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  Nitric Oxide Synthase in Human Parathyroid Glands and Parathyroid Adenomas.

Authors:  Lena Luts; Anders Bergenfelz; Jan Alumets; Frank Sundler
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.